Cellebrite DI reported strong Q1 FY24 results with revenue up 26% YoY, ARR at $331.8 million, and EPS beating consensus. Outlook remains positive with expected revenue of $90M-$94M in Q2 and $370M-$380M for FY24.
ARK Israel Innovative Technology ETF (BATS:IZRL – Get Free Report) rose 2.7% during mid-day trading on Thursday . The stock traded as high as $19.70 and last traded at $19.70. Approximately 10,277 shares were traded during mid-day trading, The stock had previously closed at $19.18. ARK Israel Innovative Technology ETF Stock Up 0.6 % The […]
ARK Israel Innovative Technology ETF (BATS:IZRL) Trading Up 0% theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
IZRL: Long-Term Comeback Candidate, Strong Buy seekingalpha.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from seekingalpha.com Daily Mail and Mail on Sunday newspapers.
US imposes sanctions on Israeli individuals for alleged settler-related violence in West Bank, signaling dissatisfaction with Israeli policies and supporting two-state solution for Israelis and Palestinians.